ORBIMED ADVISORS LLC

Position in AZN — Astrazeneca PLC

CIK 1055951 New York, NY

Position in AZN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$173,635,034

+$41,458,190 QoQ

Shares Held

915,700

+36.6% QoQ

Ownership

0.059%

of shares outstanding

% of Portfolio

3.44%

of 13F equity value

Holder Rank

#101

of 1,459 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $634,822,752 across 5 Drug Manufacturers - General names. AZN ranks #2 (27.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	257,900	$309,333,022
2	AZN	Astrazeneca PLC This page	915,700	$173,635,034
3	MRK	Merck & Co., Inc.	663,400	$85,246,900
4	BMY	Bristol Myers Squibb Co	925,000	$53,298,500
5	BIIB	Biogen Inc.	61,600	$13,309,296

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$173,635,034	915,700	+36.6%	Shares	Sole	2026-08-14
2026-03-31	$132,176,844	670,200	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.